Differences identified in depression severity, symptom burden, and depression careRead More
Posted by Physicians Weekly | Mar 5, 2020
The severity of osteoporosis in SMID started during the growth period and seems to be caused by a...Read More
Maintaining phosphorus balance in in-center hemodialysis (ICHD) patients is problematic despite recommended dietary restriction, dialysis, and phosphate binder use. Rarely is P content in prescribed medications considered, but...Read More
Naltrexone and nalmefene are approved for the treatment of alcohol use disorders, in different countries. Naltrexone is also approved for the treatment for opioid use disorders, most recently in a depot formulation. These...Read More
Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails.
Medications for opioid use disorder (OUD) are the most effective treatment for OUD, but uptake of these life-saving medications has been extremely limited in US prisons and jail settings, and limited data are available to guide...Read More
Long-term engagement in opioid agonist therapy (OAT) has been consistently associated with reduced risk for morbidity and mortality in people with opioid use disorder (OUD). However, the dynamic nature of...Read More
Psychosocial Factors Associated with Sleep Quality and Duration Among Older Adults with Chronic Pain.
Sleep complaints are common among older adults with chronic pain. Because of the risk of significant side effects, sleep medications are not recommended as first-line treatments. Little is known about the association between...Read More